Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 monthsBiomarker analysis confirms immune activatio ...
Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...
Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...
"Despite how they're being marketed and perceived by the public, these water bead gel blasters can have devastating ...
The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.
The American Society of Clinical Oncology (ASCO) and Oncology Nursing Society (ONS ... staff training and comprehensive ...
The ASCO-ONS standards for administration of antineoplastic therapy provide a comprehensive framework for ensuring patient ...
The strategy, called gene drive, pushes a genetic variant into a population that then retools HSV DNA, which then targets latent, infected neurons. If successful, it would be the second gene therapy ...
In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment ...
Topline results from registration-directed trial of ziftomenib in R/R NPM1-mutant AML expected in early 2025; Phase 1 results published in The ...
Post-election politics were very much in the air among guests at the Society of Memorial Sloan Kettering Cancer Center's fall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback